Cellectis S.A. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K, filed on November 3, 2022, by Cellectis S.A., a foreign private issuer based in Paris, France, incorporates by reference the company's interim report for the nine-month period ended September 30, 2022. The filing serves to update U.S. investors on the company's status and incorporates the interim report into existing registration statements (Form F-3 and Form S-8).
Financial Metrics
The provided text is a cover sheet and does not contain specific financial data. Consequently, values for revenue, profit, cash flow, margins, debt, and liquidity are not available in this excerpt. The filing text does not provide a clear value for any financial metric.
Material Changes
No material changes versus the prior comparable period are detailed in the provided text, as the specific content of the interim report is not included in this filing excerpt.
Guidance, Outlook, and Risks
The text does not contain management commentary, forward-looking guidance, specific risk factors, contingencies, or unusual items. These details are contained within the attached Exhibit 99.1 (the interim report), which is referenced but not reproduced in the input.
Key Facts for Investor Verification
- Verify the full content of Exhibit 99.1 (Interim Report for the nine months ended September 30, 2022) for actual financial performance data.
- Confirm the incorporation of this report into registration statements Form F-3 (No. 333-265826) and multiple Form S-8 filings.
- Note that the filing was signed by André Choulika, Chief Executive Officer, on November 3, 2022.